Vimarsana
Biggest News Aggregation in the World

Arvind Trindade News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arvind Trindade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arvind Trindade Today - Breaking & Trending Today

New study shows that WATS3D increases diagnostic yield of dysplasia in Barrett's esophagus, regardless of segment length - Vimarsana News

New study shows that WATS3D increases diagnostic yield of dysplasia in Barrett's esophagus, regardless of segment length

/PRNewswire/ -- CDx Diagnostics, Inc., developer of the WATS3D AI Platform for the detection and surveillance of Barrett's esophagus (BE) and dysplasia,...

'Medically Relevant to Saving the Life of Your Patient': What We Heard This Week - Vimarsana News

'Medically Relevant to Saving the Life of Your Patient': What We Heard This Week

Quotable quotes heard by <em>MedPage Today</em>'s reporters

Study: ChatGPT fails to pass American College of Gastroenterology tests - Vimarsana News

Study: ChatGPT fails to pass American College of Gastroenterology tests

A study published in The American Journal of Gastroenterology found two versions of ChatGPT flunked tests gauged to determine if one would pass an actual board exam.

In a Reminder of AI's Limits, ChatGPT Fails Gastro Exam - Vimarsana News

In a Reminder of AI's Limits, ChatGPT Fails Gastro Exam

Both versions of the AI model failed to achieve the 70% accuracy threshold to pass

Can an Agile Endoscopic Device Curb PPI-Dependent GERD? - Vimarsana News

Can an Agile Endoscopic Device Curb PPI-Dependent GERD?

email article Endoscopic full-thickness fundoplication (EFTP) with a novel device significantly improved quality of life and severity of symptoms in gastroesophageal reflux disease (GERD) compared with a sham procedure, a randomized study in India found. The single-center trial's primary endpoint of a 50% or greater improvement in health-related quality of life (GERD-HRQL) score at 3 months was achieved by 65.7% of patients in the EFTP group compared with 2.9% in the sham group ( P 0.001), reported Rakesh Kalapala, MD, and colleagues at the Asian Institute of Gastroenterology in Hyderab...